How to Read Your Cholesterol Blood Test Results

Last reviewed: April 2026  |  Reading time: 12 minutes
Based on: 2026 ACC/AHA Dyslipidemia Guideline · AHA/ACC Pooled Cohort Equations · USPSTF Statin Guidance

You just got your lipid panel results. Your doctor glanced at them, said something like “your cholesterol is a little high,” and sent you on your way. Now you’re staring at a page full of numbers with no idea what any of them actually mean for you.

This guide walks through every number on a standard cholesterol blood test — what it measures, what the ranges mean, and what actually matters for your cardiovascular risk. By the end, you’ll understand your results better than most people who’ve been managing their cholesterol for years.


What is a lipid panel?

A lipid panel — also called a lipid profile or cholesterol panel — is a blood test that measures the fats circulating in your bloodstream. Most panels require fasting for 9–12 hours beforehand, though non-fasting panels are increasingly common for routine screening.

A standard lipid panel measures four things:

Some panels also include non-HDL cholesterol, which is calculated automatically. More advanced panels may include ApoB or Lp(a), though these are rarely ordered as routine.


Total cholesterol — why it matters less than you think

What it is: The sum of all cholesterol in your blood — LDL, HDL, VLDL, and other fractions.

ResultCategory
Under 200 mg/dLDesirable
200–239 mg/dLBorderline high
240+ mg/dLHigh

What your doctor isn’t telling you: Total cholesterol alone is a poor predictor of cardiovascular risk. HDL cholesterol is protective — it reduces your risk — but it’s included in the total. Someone with total cholesterol of 220 mg/dL could have HDL of 80 mg/dL and LDL of 100 mg/dL — a very favorable profile — while someone with total cholesterol of 190 mg/dL could have HDL of 30 mg/dL and LDL of 140 mg/dL, which is far more concerning.

The practical takeaway: Total cholesterol tells you there might be something worth examining. It doesn’t tell you what the problem is or how serious it is. Always look at the individual components.

LDL cholesterol — the number your doctor focuses on most

What it is: LDL particles carry cholesterol from the liver to cells throughout the body. When LDL levels are elevated, cholesterol can accumulate in artery walls, contributing to atherosclerosis — the buildup of plaque that underlies most heart attacks and strokes.

ResultCategory
Under 70 mg/dLOptimal for very high-risk patients
Under 100 mg/dLOptimal for high-risk patients
100–129 mg/dLNear optimal / above optimal
130–159 mg/dLBorderline high
160–189 mg/dLHigh
190+ mg/dLVery high

Important nuance: These are population categories, not personal targets. Your LDL target depends entirely on your overall cardiovascular risk profile — not just the number itself. An LDL of 140 mg/dL in a 45-year-old with no risk factors is treated very differently from an LDL of 140 mg/dL in a 65-year-old with diabetes and high blood pressure.

The LDL calculation problem: Most lipid panels don’t actually measure LDL directly. They calculate it using the Friedewald equation:

LDL = Total Cholesterol − HDL − (Triglycerides ÷ 5)

This formula becomes inaccurate when triglycerides are above 400 mg/dL. If your triglycerides are elevated, ask your doctor whether a direct LDL measurement makes sense. The Martin-Hopkins equation is a more accurate alternative now available on some panels.


HDL cholesterol — the number you want higher

What it is: HDL particles transport cholesterol away from artery walls back to the liver for processing and elimination. Higher HDL is generally protective against cardiovascular disease.

ResultCategory
Under 40 mg/dL (men) / Under 50 mg/dL (women)Low — considered a risk factor
40–59 mg/dLAcceptable
60+ mg/dLHigh — considered protective

What the research shows: The relationship between HDL and cardiovascular risk is more complex than “higher is always better.” A 2012 Mendelian randomization study published in The Lancet found that genetic variants that raise HDL do not necessarily reduce heart attack risk — suggesting that HDL’s protective effect may depend on its function, not just its level.

What raises HDL naturally:


Triglycerides — the overlooked number

What it is: Triglycerides are the most common type of fat in the body. Elevated triglycerides are often associated with insulin resistance, excess carbohydrate intake, alcohol use, and certain medications.

ResultCategory
Under 150 mg/dLNormal
150–199 mg/dLBorderline high
200–499 mg/dLHigh
500+ mg/dLVery high — pancreatitis risk
If your triglycerides are 500+ mg/dL: This significantly increases the risk of acute pancreatitis — a potentially life-threatening condition. This is not an “optimize with supplements” situation. Speak with a clinician promptly.

Triglycerides are highly responsive to dietary changes. The biggest drivers are refined carbohydrates and sugar — not dietary fat. Reducing sugary drinks, white bread, white rice, and alcohol can produce meaningful reductions within weeks.


Non-HDL cholesterol — the underrated marker

What it is: Non-HDL = Total Cholesterol − HDL. It captures all the cholesterol in potentially atherogenic particles: LDL, VLDL, IDL, and Lp(a).

Non-HDL is a better predictor of cardiovascular risk than LDL alone in several populations — especially people with elevated triglycerides, diabetes, or obesity, where LDL calculation is less reliable. The 2018 ACC/AHA guideline formally recognized non-HDL as a secondary treatment target.

Risk levelNon-HDL target
Low riskUnder 130 mg/dL
Moderate riskUnder 100 mg/dL
High riskUnder 100 mg/dL
Very high riskUnder 70 mg/dL

The numbers your panel probably didn’t include — but should

ApoB (Apolipoprotein B)

Every atherogenic particle — every LDL, VLDL, IDL, and Lp(a) particle — carries exactly one ApoB protein. So ApoB gives you a direct count of the number of potentially dangerous particles in your blood.

LDL cholesterol tells you how much cholesterol is being carried; ApoB tells you how many carrier particles exist. Two people with identical LDL-C can have very different ApoB levels — and the person with more particles may have meaningfully higher risk.

A 2021 meta-analysis in The Lancet found that ApoB was more strongly associated with cardiovascular events than LDL-C, particularly in people with metabolic syndrome or diabetes.

What to ask your doctor: “Can you add ApoB to my next lipid panel?” It’s a simple blood test, often covered by insurance, and rarely ordered proactively.

Lp(a) — Lipoprotein(a)

Lp(a) is a modified LDL particle with an additional protein attached. Elevated Lp(a) is an inherited cardiovascular risk factor that standard lipid panels don’t measure. It affects roughly 1 in 5 people and can significantly increase risk even when LDL appears normal.

The 2022 ACC Expert Consensus Decision Pathway recommends measuring Lp(a) at least once in every adult to identify those at elevated baseline risk.


How to interpret your results together — not in isolation

Pattern 1: High LDL, normal HDL, normal triglycerides
The classic “isolated high LDL” pattern. Risk depends heavily on your other cardiovascular risk factors: age, blood pressure, smoking status, diabetes, family history.

Pattern 2: Normal LDL, low HDL, high triglycerides
The metabolic syndrome pattern — often associated with insulin resistance and high refined carbohydrate intake. LDL appears “normal” but the overall risk profile can be significant.

Pattern 3: High LDL with other risk factors
When LDL elevation is accompanied by diabetes, hypertension, smoking, or family history of early heart disease, the threshold for clinical intervention shifts significantly.

Pattern 4: Very high LDL (190+ mg/dL)
At this level, the 2026 ACC/AHA guideline recommends clinical evaluation and statin therapy discussion regardless of other risk factors.


Questions worth bringing to your next appointment

Find out what your numbers mean for you

Your lipid panel gives you data. What it doesn’t give you is a personalized interpretation — what your specific combination of numbers means for someone your age, with your risk factors, and your treatment preferences.

Take the 2-minute quiz → Free · No account required · Based on 2026 clinical guidelines

Sources

  1. Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. JACC. 2019;73(24):e285-e350. PMID: 30423393
  2. Voight BF, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572-580. PMID: 22607825
  3. Sniderman AD, et al. A meta-analysis of LDL-C, non-HDL-C, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337-345. PMID: 21487090
  4. Marston NA, et al. Association Between Apolipoprotein B and Cardiovascular Disease. Lancet. 2021. PMID: 33444233
  5. Lloyd-Jones DM, et al. 2022 ACC Expert Consensus on Nonstatin Therapies for LDL-C Lowering. JACC. 2022;80(14):1366-1418. PMID: 36031461
  6. Martin SS, et al. Friedewald-estimated versus directly measured LDL cholesterol. JACC. 2013;62(8):732-739. PMID: 23770179
  7. Santos FL, et al. Meta-analysis of low carbohydrate diets on cardiovascular risk factors. Obes Rev. 2012;13(11):1048-1066. PMID: 22905670
This article is for educational purposes only and does not constitute medical advice. Consult a licensed clinician before making any changes to your medication or supplement regimen.